Atherosclerosis: Volume 340 to Volume 363

Certainly, let’s continue:

9. Emerging Technologies: Atherosclerosis recognizes the role of technological advancements in advancing our understanding of vascular diseases. Contributions discussing emerging technologies such as imaging modalities, biomarkers, and genomic approaches are welcomed. These technologies offer new avenues for early detection, risk stratification, and personalized treatment.
10. Preventive Strategies: The journal places importance on research that contributes to preventive strategies against atherosclerosis. This includes studies on lifestyle modifications, public health interventions, and community-based initiatives aimed at reducing the burden of atherosclerotic diseases.
11. International Collaboration: Atherosclerosis encourages international collaboration in research and the sharing of diverse perspectives. The global nature of atherosclerosis requires insights from different regions and populations, and the journal serves as a conduit for fostering collaboration among researchers and clinicians worldwide.
12. Patient-Centered Approaches: Recognizing the significance of patient-centered care, the journal welcomes studies that explore the impact of atherosclerosis on patients’ quality of life, adherence to treatment, and the incorporation of patient perspectives in shaping healthcare policies.

In summary, Atherosclerosis continues to be at the forefront of cardiovascular research, embracing a holistic approach to understanding and managing atherosclerosis. Through its inclusive scope, the journal aims to facilitate dialogue, drive innovation, and ultimately contribute to the global efforts in preventing and treating atherosclerotic diseases. The diverse range of topics covered ensures that Atherosclerosis remains a vital resource for professionals across various disciplines involved in cardiovascular health.